MedImmune Seeks Portfolio Expansion with Medarex Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 55 (Table of Contents)
Published: 5 Jan-2005
DOI: 10.3833/pdr.v2005.i55.732 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
MedImmune and Medarex entered into research & development agreement for Medarex’s MDX-1103 and MDX-1333 antibodies that are in preclinical trials for treating autoimmune diseases such as systemic lupus erythematosus...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS